openPR Logo
Press release

Bispecific Antibody Market Set New Growth Story 2026 | Amgen, AstraZeneca, Sanofi, Regeneron Pharmaceuticals, Inc, Eli Lilly and Company, Novartis, Celgene

04-16-2020 04:15 PM CET | Health & Medicine

Press release from: databridgemarketresearch

Bispecific Antibody Market - Industry Trends and Forecast to 2026

Bispecific Antibody Market - Industry Trends and Forecast to 2026

Global bispecific antibody market is expected to grow at a growing CAGR in the forecast period of 2019-2026. Increase in strategic alliances between the pharmaceuticals companies and high demand of disease specific novel therapies are the key factors that fueling the market growth.Global Bispecific Antibody Market By Type (Immunoglobulin G (IgG) Like Molecule, Non Immunoglobulin G (IgG) Like Molecule), Mechanism of Action (Bispecific Diabodies, Bispecific T-Cell Engager Antibodies), Application (Oncology, Autoimmune Disease and Others), Drugs (Blinatumomab, Catumaxomab, Duligotumab and Others), Route of Administration (Oral, Injectable), End- Users (Hospitals, Specialty Clinics and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies), Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) - Industry Trends and Forecast to 2026.

Click Here To Get Global Bispecific Antibody Market Research Sample PDF Copy @https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-bispecific-antibody-market&skp

Key Market Players:Global Bispecific Antibody Market

Few of the major competitors currently working in the global bispecific antibody market are Adimab, Innovent Biologics, Inc, Affimed GmbH, Amgen Inc, AstraZeneca, Xencor, Sanofi, F. Hoffmann-La Roche Ltd, Regeneron Pharmaceuticals Inc, Eli Lilly and Company, Xencor, Pieris Pharmaceuticals, Inc, Mereo BioPharma Group plc, Sobi, TG Therapeutics, Inc, Merus, MacroGenics, Inc, Genmab A/S, Emergent BioSolutions Inc, Alteogen, Astellas Pharma Inc, Novartis AG, CELGENE CORPORATION and others.

Market Definition: Global Bispecific Antibody Market

Bispecific antibodies are designed to elicit multifaceted biological effects that require simultaneous binding to two different antigen targets with one molecule. It can be employed wide range of therapeutics application including bind multiple targets, to block multiple pathogenic pathways, target tumor heterogeneity, increase specificity, synergistically induce enhanced therapeutic effects and others.

Market Drivers

o Ongoing clinical trial conducted by many pharmaceuticals industries is propelling the growth of this market
o Increase in special designation from the regulatory authorities is boosting the market growth
o Major advancements in linker technology is likely to drive the market
o High demand of disease specific novel treatment can also act as a market driver
o The competitive scenario of market and strategic collaborations may boost the market position

Market Restraints

o Limited operating revenue opportunities for research and development of targeted therapies by many pharmaceuticals is acting as a challenging factor for the growth of this market
o Low healthcare budget in some developing countries is hamper the market growth
o Patent expiration of branded drugs and introduction of generics is also hinders the market growth

Segmentation: Global Bispecific Antibody Market

By Type

o Immunoglobulin G (IgG) Like Molecule
o Non Immunoglobulin G (IgG) Like Molecule

By Mechanism of Action

o Bispecific Diabodies
o Bispecific T-Cell Engager Antibodies

By Application

o Oncology
o Autoimmune Disease
o Others

By Drugs

o Blinatumomab
o Catumaxomab
o Duligotumab
o Others

By Route of Administration

o Oral
o Injectable

By End Users

o Hospitals
o Specialty Clinics
o Others
By Distribution Channel
o Hospital Pharmacies
o Retail Pharmacies
By Geography

o Europe
o Asia-Pacific
o South America

Key Developments in the Market:

o In April 2019, Innovent Biologics, Inc in collaboration with Eli Lilly and Company initiated phase I trial of IBI318, a recombinant fully human IgG1 bispecific antibody targeting PD-1 and PD-L1 for the treatment of advanced malignancies. If trial successful, it will change the treatment landscape and improve the lives of millions of patients suffering from advanced malignancies.
o In June 2019, Regeneron Pharmaceuticals Inc reported topline positive results of REGN1979, a bispecific monoclonal antibody that targets B-cell tumor protein (CD20) and an immune system T-cell receptor (CD3) is developing for the treatment of relapsed or refractory (R/R) B-cell non-Hodgkin lymphoma. The trial demonstrated, 93% overall response (13 of 14 patients) and 71% complete response rates. If trial successful, expanding their market share and emphasizing their superiority.

Competitive Analysis:

Global bispecific antibody market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares global bispecific antibody market for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Bispecific Antibody Reports Includes The Following Deliverable
o Macro Indicator Analysis
o Bispecific Antibody Market Overview
o Market Dynamics
o Drivers, Restraints, Opportunities and Challenges
o Market sizing and growth analysis
o Global Bispecific Antibody Market forecasting to 2025
o Market Competitive Landscape
o Product Launches and Pipeline Analysis
o Value Chain Analysis
o Market Mergers, Acquisitions and Agreements
o Company Profiles

This report scope includes a holistic study of the current dynamics of the market, industry growth and restraints of the Global Bispecific Antibody Market. It provides the market forecast to 2025, recent developments in the market and pipeline analysis of the major players. The report also includes a review of micro and macro forecasts, new entrant strategies, and market penetration strategies with a comprehensive value chain analysis.

Table Of Contents: Global Bispecific Antibody Market
Part 01: Executive Summary
Part 02: Scope Of The Report
Part 03: Research Methodology
Part 04: Market Landscape
Part 05: Pipeline Analysis
Part 06: Market Sizing
Part 07: Five Forces Analysis
Part 08: Market Segmentation
Part 09: Customer Landscape
Part 10: Regional Landscape
Part 11: Decision Framework
Part 12: Drivers And Challenges
Part 13: Market Trends
Part 14: Vendor Landscape
Part 15: Vendor Analysis
Part 16: Appendix

Browse TOC with selected illustrations and example pages of Global Bispecific Antibody Market @https://www.databridgemarketresearch.com/toc/?dbmr=global-bispecific-antibody-market&skp

Key Questions Answered in Bispecific Antibody Report

o What will the Global Bispecific Antibody Market size be in 2025 and what will the growth rate be?
o What are the key market trends?
o What is driving this market?
o What are the challenges to market growth?
o Who are the key vendors in this market space?
o What are the market opportunities and threats faced by the key vendors?

Key Reason To Purchase The Bispecific Antibody Report

1. To describe and forecast the Global Bispecific Antibody Market, in terms of value, by process, product type, and industry.
2. To strategically profile key players and comprehensively analyze their market position in terms of ranking and core competencies, and detail the competitive landscape for market leaders
3. To describe and forecast the market, in terms of value, for various segments, by region North America, Europe, Asia Pacific (APAC), and Rest of the World (RoW)
4. To provide detailed information regarding the major factors (drivers, restraints, opportunities, and challenges) influencing the Global Bispecific Antibody Market growth
5. Market Development: Comprehensive information about emerging markets. This report analyzes the market for various trocars across geographies.
6. To strategically analyze micro markets with respect to individual growth trends, prospects, and contribution to the overall market

Key Focus Of The Bispecific Antibody Report

1. This report provides pin-point analysis for changing competitive dynamics
2. It provides a forward-looking perspective on different factors driving or restraining market growth
3. It provides five-year forecast assessed on the basis of how the market is predicted to grow
4. It helps in understanding the key product segments and their future
5. It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
6. It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

Customization of the Report

o The report includes the complete segmentation displayed above across all above mentioned countries
o All products covered in the Global Bispecific Antibody Market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization)

Any Questions? Inquire here before purchase @https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-bispecific-antibody-market&skp

Note: If you have any special requirements, please let us know and we will offer you the report as you want.

Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Europe, MEA or Asia Pacific.

Contact Us:

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Email:Corporatesales@databridgemarketresearch.com

About Data Bridge Market Research:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Bispecific Antibody Market Set New Growth Story 2026 | Amgen, AstraZeneca, Sanofi, Regeneron Pharmaceuticals, Inc, Eli Lilly and Company, Novartis, Celgene here

News-ID: 2013742 • Views: 1788

More Releases from databridgemarketresearch

Single Factor Authentication System Market Next Big Thing - 2027 | Safran, NEC T …
The purpose of this Single Factor Authentication System Market research report is to endow you with an absolute insights and awareness of the greatest market opportunities into the applicable markets. By applying business intelligence, the report is organized which provides thorough and extensive market insights. The report is mainly delivered in the form of PDF or spreadsheet. This ultimately helps for successful business growth which can be accomplished only with
Night Vision System Market To Witness Astonishing Growth - 2027 with Autoliv , D …
This Night Vision System Market research report performs the methodical and comprehensive market research study that puts forth the facts and figures linked with any subject about ICT industry. Night Vision System Market report brings into focus plentiful of factors such as the general market conditions, trends, inclinations, key players, opportunities, and geographical analysis which all aids to take your business towards the growth and success. The report provides with
Ultrasonic Motion Sensor Market is Thriving with Rising Latest Trends by 2027 | …
This global Ultrasonic Motion Sensor Market research report offers you with an array of insights about ICT industry and business solutions that will support you stay ahead of the competition. All statistical and numerical data included in the report is characterized with the help of graphs and charts which makes it easy to understand the facts and figures. This Ultrasonic Motion Sensor Market report comprises of most-detailed market segmentation, systematic
Laser Phosphor Display (LPD) Market Business Opportunities With Top Market Playe …
This professional business report focuses on primary and secondary drivers, market share, market size, leading segments and geographical analysis. Laser Phosphor Display (LPD) Market research report is an ideal guide to attain an information or key data about market, emerging trends, product usage, motivating factors for customers, competitor strategies, brand positioning, customer preferences, and customer behaviour. This market report gives wide-ranging analysis of the market structure and the evaluations of

All 5 Releases


More Releases for Bispecific

Bispecific Antibodies Market Opportunity Analysis, 2018-2026
Bispecific antibody (BsAb) is an artificial protein that is composed of fragments of two different monoclonal antibodies and has ability to bind to two different types of antigen. Cancer immunotherapy is the most widely explored application of bispecific antibody. Lung, breast and colon cancer are the wider applications of BsAb. Bispecific antibody simultaneously binds to a cytotoxic cell and target tumor cell and destroys it. Bispecific antibodies are emerging a
Engineered Bispecific Antibodies (BsAb) Novel Approaches & Pipeline Insights, 20 …
Engineered Bispecific Antibodies (BsAb) Wiseguyreports.Com Adds “Engineered Bispecific Antibodies (BsAb) Market -Market Demand, Growth, Opportunities, Manufacturers, Analysis of Top Key Players and Forecast to 2022” To Its Research Database. Get Sample Report @ https://www.wiseguyreports.com/sample-request/476535-engineered-bispecific-antibodies-bsab-novel-approaches-pipeline-insights-2016 Covered In This Report: Summary DelveInsight Report, “Engineered Bispecific Antibodies (BsAb) Novel Approaches & Pipeline Insights, 2016” emphasizes on the novel bispecific antibodies technologies in research and development. The report enlists company, target antigens, phase and indication
Bispecific Antibodies Market, Company Analysis and Forecast to 2024
Bispecific Antibodies Market Overview Bispecific antibody (BsAb) is an artificial protein that is composed of fragments of two different monoclonal antibodies and has ability to bind to two different types of antigen. Cancer immunotherapy is the most widely explored application of bispecific antibody. Lung, breast and colon cancer are the wider applications of BsAb. Bispecific antibody simultaneously binds to a cytotoxic cell and target tumor cell and destroys it. Bispecific antibodies
Bispecific Antibodies Market - Global Industry Analysis 2024
Bispecific Antibodies Market Overview Bispecific antibody (BsAb) is an artificial protein that is composed of fragments of two different monoclonal antibodies and has ability to bind to two different types of antigen. Cancer immunotherapy is the most widely explored application of bispecific antibody. Lung, breast and colon cancer are the wider applications of BsAb. Bispecific antibody simultaneously binds to a cytotoxic cell and target tumor cell and destroys it. Bispecific antibodies
Bispecific Antibodies Market to Grow Globally
Bispecific Antibodies Market Overview Bispecific antibody (BsAb) is an artificial protein that is composed of fragments of two different monoclonal antibodies and has ability to bind to two different types of antigen. Cancer immunotherapy is the most widely explored application of bispecific antibody. Lung, breast and colon cancer are the wider applications of BsAb. Bispecific antibody simultaneously binds to a cytotoxic cell and target tumor cell and destroys it. Bispecific antibodies
Bispecific Antibodies Market - Global Industry Analysis 2024
Bispecific Antibodies Market Overview Bispecific antibody (BsAb) is an artificial protein that is composed of fragments of two different monoclonal antibodies and has ability to bind to two different types of antigen. Cancer immunotherapy is the most widely explored application of bispecific antibody. Lung, breast and colon cancer are the wider applications of BsAb. Bispecific antibody simultaneously binds to a cytotoxic cell and target tumor cell and destroys it. Bispecific antibodies